Vnitr Lek 2011, 57(3):293-298
Microalbuminuria. From diabetes to cardiovascular risk
- 1 Interní klinika 1. lékařské fakulty UK a ÚVN Praha, přednosta prof. MUDr. Miroslav Zavoral, Ph.D.
- 2 Nefrologická ambulance Synlab Czech s.r.o. Praha
An increased albuminuria level, known as microalbuminuria is associated with a range of diseases, most frequently with diabetes mellitus and hypertension. Microalbuminuria in type 1 diabetes is an early sign of diabetic nephropathy onset, while it tends to be an indicator of the level of cardiovascular risk in type 2 diabetes and essential hypertension. At present, an increased albumin excretion is considered to be a renal symptom of generalized endothelial dysfunction. A simple investigation, not bothersome to a patient, should be performed early and repeatedly in all patients with diabetes and hypertension, as low microalbuminaemia levels can be managed with appropriate treatment.
Keywords: microalbuminuria; diabetes mellitus; hypertension; endothelial dysfunction; cardiovascular risk
Received: January 10, 2011; Published: March 1, 2011 Show citation
References
- Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria? Kidney Int 2006; 70: 1214-1222.
Go to original source...
Go to PubMed...
- Lambers Heerspink HJ, Brantsma AH, de Zeeuw D et al. PREVEND Study Group. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 2008; 168: 897-905.
Go to original source...
Go to PubMed...
- Busby DE, Bakris GL. Comparison of commonly used assays for the detection of microalbuminuria. J Clin Hypertens 2004; 6 (Suppl 3): 8-12.
Go to original source...
Go to PubMed...
- Levey AS, Eckardt KU, Tsukamoto et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improve Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
Go to original source...
Go to PubMed...
- de Zeeuw D, Parving HH, Hening RH et al. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006; 17: 2100-2105.
Go to original source...
Go to PubMed...
- Comper WD, Osicka TM, Clark M et al. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 2004; 65: 1850-1855.
Go to original source...
Go to PubMed...
- Ewald B, Attia J. Which test to detect microalbuminuria in diabetic patients? A systematic review. Aust Fam Physician 2004; 33: 565-568.
Go to PubMed...
- de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol 2006; 17: 2120-2126.
Go to original source...
Go to PubMed...
- The American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care 2009; 32 (Suppl 1): S13-S61.
Go to PubMed...
- Hillege HL, Janssen WM, Bak AA et al. Prevend Study Group. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249: 519-526.
Go to original source...
Go to PubMed...
- Romundstad S, Holmen J, Kvenild K et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: A 4.4-year follow-up study The Nord-Trøndelag Health Study (HUNT), Norway. Am J Kidney Dis 2003; 42: 466-473.
Go to original source...
Go to PubMed...
- Jones CA, Francis ME, Eberhardt MS et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445-459.
Go to original source...
Go to PubMed...
- Tapp RJ, Shaw JE, Zimmet PZ et al. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis 2004; 44: 792-798.
Go to original source...
Go to PubMed...
- Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
Go to original source...
Go to PubMed...
- Parving HH, Lewis JB, Ravid M et al. DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006; 69: 2057-2063.
Go to original source...
Go to PubMed...
- Wachtell K, Palmieri V, Olsen MH et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002; 143: 319-326.
Go to original source...
Go to PubMed...
- Böhm M, Thoenes M, Danchin N et al. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. J Hypertens 2007; 25: 2317-2324.
Go to original source...
Go to PubMed...
- Agrawal B, Berger A, Wolf K et al. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996; 14: 223-228.
Go to original source...
Go to PubMed...
- Cerasola G, Mulé G, Nardi E et al. Hypertension, microalbuminuria and renal dysfunction. The Renal Dysfunction in Hypertension (REDHY) study. J Nephrol 2008; 21: 368-373.
Go to PubMed...
- Leoncini G, Viazzi F, Rosei EA et al. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens 2010; 28: 2317-2324.
Go to original source...
Go to PubMed...
- de Zeeuw D, Remuzzi G, Parving HH et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110: 921-927.
Go to original source...
Go to PubMed...
- Cerasola G, Cottone S, Mulè G. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor. J Hypertens 2010; 28: 2357-2369.
Go to original source...
Go to PubMed...
- Basi S, Lewis JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis 2006; 47: 927-946.
Go to original source...
Go to PubMed...
- Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005; 54: 1626-1634.
Go to original source...
Go to PubMed...
- Ochodnicky P, Henning RH, van Dokkum RP et al. Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage. J Cardiovasc Pharmacol 2006; 47 (Suppl 2): S151-S162.
Go to original source...
Go to PubMed...
- Rüster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 2006; 17: 2985-2991.
Go to original source...
Go to PubMed...
- Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 2-35.
Go to original source...
Go to PubMed...
- Menne J, Chatzikyrkou Ch, Haller H. Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockade. J Hypertens 2010; 28: 1983-1994.
Go to original source...
Go to PubMed...
- Ärnlöv J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-975.
Go to original source...
Go to PubMed...
- Jager A, Kostense PJ, Ruhé HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects. Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624.
Go to original source...
Go to PubMed...
- Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
Go to original source...
Go to PubMed...
- Gerstein HC, Mann JFE, Yi Q et al. HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
Go to original source...
Go to PubMed...
- Valmadrid CT, Klein R, Moss SE et al. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-1100.
Go to original source...
Go to PubMed...
- Wachtell K, Ibsen H, Olsen MH et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139: 901-906.
Go to original source...
Go to PubMed...
- Yuyun MF, Dinneen SF, Edwards OM et al. Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabet Med 2003; 20: 277-282.
Go to original source...
Go to PubMed...
- O'Hare AM, Hailpern SM, Pavkov ME et al. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Arch Intern Med 2010; 170: 930-936.
Go to original source...
Go to PubMed...
- Berton G, Cordiano R, Palmieri R et al. Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality. Diabetologia 2004; 47: 1511-1518.
Go to original source...
Go to PubMed...
- Berton G, Cordiano R, Mazzuco S et al. Albumin excretion in acute myocardial infarction: A guide for long-term prognosis. Am Heart J 2008; 156: 760-768.
Go to original source...
Go to PubMed...
- Yuyun MF, Khaw KT, Luben R et al. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med 2004; 255: 247-256.
Go to original source...
Go to PubMed...
- Özyilmaz A, Bakker SJ, de Zeeuw D et al. PREVEND Study Group. Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors. Nephrol Dial Transplant 2010; 25: 3560-3568.
Go to original source...
Go to PubMed...
- Hallan S, Astor B, Romundstad S et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 2007; 167: 2490-2496.
Go to original source...
Go to PubMed...
- Chronic Kidney Disease Prognosis Consortium. Matsushita K, van der Velde M, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
Go to original source...
Go to PubMed...
- Mancia G, De Backer G, Dominiczak A et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1087.
Go to original source...
Go to PubMed...
- Chobanian AV, Bakris GL, Black HR et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
Go to original source...
Go to PubMed...
- Ogihara T, Kikuchi K, Matsuoka H et al. Japanese Society of Hypertension Committee. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
Go to original source...
- Ruggenenti P, Fassi A, Ilieva AP et al. Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators. Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351: 1941-1951.
Go to original source...
Go to PubMed...
- Mann JFE, Schmieder RE, Dyal L et al. TRANSCEND (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators. Effect of Telmisartan on Renal Outcomes: A Randomized Trial. Ann Intern Med 2009; 151: 1-10.
Go to original source...
Go to PubMed...
- Bilous R, Chaturvedi N, Sjølie AK et al. Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes: Three Randomized Trials. Ann Intern Med 2009; 151: 11-20.
Go to original source...
Go to PubMed...
- Mauer M, Zinman B, Gardiner R et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009; 361: 40-51.
Go to original source...
Go to PubMed...
- Haller H, Ito S, Izzo JL Jr et al. Prevention of microalbuminuria: in type 2 diabetes (Roadmap Trial). J Hypertension 2010; 28: 233.
Go to original source...
- Haller J, Ito S, Izzo JL et al. Prevention of microalbuminuria: Predictors for a good response to olmesartan treatment (Roadmap Trial). J Hypertension 2010; 28: 275.
Go to original source...
- Ritz E, Viberti GC, Ruilope LM et al. Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia 2010; 53: 49-57.
Go to original source...
Go to PubMed...
- Mann JF, Schmieder RE, McQueen M et al. ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008; 372: 547-553.
Go to original source...
Go to PubMed...
- Douglas K, O'Malley PG, Jackson JL. Meta-analysis: the effect of statins on albuminuria. Ann Intern Med 2006; 145: 117-124.
Go to original source...
Go to PubMed...
- Keech A, Simes RJ, Barter P et al. FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9 795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-1861.
Go to original source...
Go to PubMed...
- Schrader J, Lüders S, Kulschewski A et al. MARPLE Study Group. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study). J Hypertens 2006; 24: 541-548.
Go to original source...
Go to PubMed...
- Bakris GL, Ruilope L, Locatelli F et al. Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: Results of the IMPROVE trial. Kidney Int 2007; 72: 879-885.
Go to original source...
Go to PubMed...
- Ibsen H, Olsen MH, Wachtell K et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertensive study. Hypertension 2005; 45: 198-202.
Go to original source...
Go to PubMed...